Literature DB >> 2907521

Lack of interaction between nizatidine and warfarin during chronic administration.

A Cournot1, I Berlin, J C Sallord, E Singlas.   

Abstract

Nizatidine is a new antagonist of H2 receptors. The nizatidine warfarin interaction was investigated in healthy volunteers during chronic warfarin (mean warfarin dose: 5 +/- 0.9 mg/d) and nizatidine (300 mg/d) administration. Nizatidine coadministration did not increase the prothrombin time, kaolin-cephalin clotting time, and did not modify the activity of clotting factors II, VII, IX, X. Nizatidine did not influence the steady-state plasma warfarin concentration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907521     DOI: 10.1002/j.1552-4604.1988.tb05727.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  2 in total

1.  Gastric fluid volume and pH after nizatidine in adults undergoing elective surgery: influence of timing and dose.

Authors:  K Mikawa; K Nishina; N Maekawa; M Asano; H Obara
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

Review 2.  Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.

Authors:  Stephen Brett
Journal:  Crit Care       Date:  2004-10-08       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.